Agilon Health (NYSE:AGL) Shares Up 10.3% – Here’s Why

Agilon Health, Inc. (NYSE:AGL) shares traded up 10.3% on Wednesday . The stock traded as high as $108.24 and last traded at $104.50. 163,457 shares traded hands during mid-day trading, a decline of 53% from the average session volume of 348,156 shares. The stock had previously closed at $94.78.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on AGL. TD Cowen restated a “hold” rating and set a $55.00 price target (up from $17.00) on shares of Agilon Health in a research note on Monday, May 11th. Weiss Ratings lowered shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 27th. Wells Fargo & Company reissued an “overweight” rating and set a $141.00 target price (up from $72.00) on shares of Agilon Health in a report on Monday, July 13th. Benchmark restated a “buy” rating and set a $95.00 target price (up from $13.00) on shares of Agilon Health in a research report on Thursday, May 21st. Finally, Wall Street Zen raised Agilon Health from a “sell” rating to a “hold” rating in a report on Saturday, May 9th. Five analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Agilon Health presently has an average rating of “Hold” and a consensus target price of $66.50.

Agilon Health Trading Up 18.6%

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a market cap of $1.88 billion, a PE ratio of -5.22 and a beta of 3.01. The stock’s 50 day simple moving average is $106.46 and its 200 day simple moving average is $54.68.

Agilon Health (NYSE:AGL) last released its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.38 billion. On average, sell-side analysts forecast that Agilon Health, Inc. will post -3.5 earnings per share for the current fiscal year.

Institutional Trading of Agilon Health

A number of hedge funds have recently bought and sold shares of AGL. AQR Capital Management LLC raised its stake in shares of Agilon Health by 243.3% during the first quarter. AQR Capital Management LLC now owns 501,440 shares of the company’s stock worth $2,171,000 after acquiring an additional 355,365 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Agilon Health by 3.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock valued at $927,000 after purchasing an additional 7,209 shares in the last quarter. Dynamic Technology Lab Private Ltd grew its holdings in shares of Agilon Health by 28.4% during the 1st quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after purchasing an additional 10,424 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Agilon Health by 6.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock valued at $21,911,000 after purchasing an additional 311,158 shares during the last quarter. Finally, Creative Planning raised its position in Agilon Health by 17.6% in the 2nd quarter. Creative Planning now owns 170,969 shares of the company’s stock worth $393,000 after purchasing an additional 25,548 shares during the period.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.